Eureka Pharma SRL
7.2 FTEThe score of Eureka Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +11 % Total assets -9 % Headcount (avg FTE) +20 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Eureka Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jun 2026
- Year ended 31 Dec 2024filed on 30 Jun 2025
- Year ended 31 Dec 2023filed on 01 Jul 2024
- Year ended 31 Dec 2022filed on 25 Aug 2023
- Year ended 31 Dec 2021filed on 23 Jul 2022
Eureka Pharma's financial analysis
- Solvency85.5%sector median: 45.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Eureka Pharma
Eureka Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0877.239.492
- VAT number
- BE0877239492
- Peppol
- Registered · 0208:0877239492 · as of 30 Oct 2026
- Legal form
- SRL
- Incorporated
- 14 Nov 2005
- Registered office
- 8520 Kuurne
- Size
- Micro · 7.2 FTE
- Latest accounts
- 2025 · filed on 30 Jun 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Eureka Pharma (SRL) has been based in Kuurne since 2005, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 15,385 € and equity of €1.62m; its revenue is not published. With 7.2 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 85.5%, above the median of its sector (45.8%).
Companies similar to Eureka Pharma
Companies in the same business, of comparable size and area, outside its group.
- Sakura Finetek Belgium Manufacture of medical and dental instruments and supplies Antwerp · balance sheet €1.89m
- Axo Industry International Manufacture of pharmaceutical preparations Wavre · balance sheet €1.63m
- Servicov Wholesale of pharmaceutical and medical goods Ghent · balance sheet €3.54m
- ICU Medical Belgium Wholesale of pharmaceutical and medical goods Leuven · balance sheet €1.91m
- Nutway Wholesale of pharmaceutical and medical goods Mons · balance sheet €1.91m
- Closson Wholesale of pharmaceutical and medical goods Wellin · balance sheet €1.60m
- Menarini Stemline Benelux NV/SA Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €2.57m
- GHX Europe Wholesale of pharmaceutical and medical goods Brussels · balance sheet €2.81m
Frequently asked questions about Eureka Pharma
What is the revenue of Eureka Pharma?
Eureka Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Eureka Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0877239492 for Eureka Pharma, if the company is VAT-registered. Its company number (CBE) is 0877.239.492.
Where is the registered office of Eureka Pharma?
According to the CBE register, the registered office of Eureka Pharma is in 8520 Kuurne.
What is the equity of Eureka Pharma?
At the close of the 2025 financial year, the equity of Eureka Pharma amounts to 1,623,331 €, a solvency of 85.5% of total assets.
How many people work at Eureka Pharma?
7.2 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Eureka Pharma?
The register lists 4 active mandates at Eureka Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Eureka Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →